CSIMarket
 

IMPACT BIOMEDICAL INC.  (NYSE: IBO)

Impact Biomedical Inc's

Competitiveness




 

IBO Sales vs. its Competitors Q2 2026







Revenue Growth Comparisons




Net Income Comparison




<<  IBO Stock Performance Comparisons


Impact Biomedical Inc's Comment on Competition and Industry Peers


Impact BioMedical operates in the specialty biopharmaceuticals, antivirals, antimicrobials, and consumer healthcare and wellness product markets. The company’s products are often derived from naturally sourced elements. Impact BioMedical faces competition from major pharmaceutical companies, specialty pharmaceutical companies, biotechnology companies, academic institutions, governmental agencies, and public and private research institutions. Its business model includes licensing and potential direct sales, with potential licensors and development partners comprising pharmaceutical, food, and consumer packaged goods companies.



*Market share is calculated based on total revenue.





Publicly Traded Peers of IMPACT BIOMEDICAL INC.



Sources: IMPACT BIOMEDICAL INC.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on IMPACT BIOMEDICAL INC. versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.